![Cindy Parseghian](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Cindy Parseghian
Fondateur chez The Ara Parseghian Medical Research Foundation
Postes actifs de Cindy Parseghian
Sociétés | Poste | Début | Fin |
---|---|---|---|
The Ara Parseghian Medical Research Foundation | Fondateur | - | - |
President | - | - | |
National Institute of Neurological Disorders & Stroke | Président | - | - |
Translational Genomics Research Institute
![]() Translational Genomics Research Institute Miscellaneous Commercial ServicesCommercial Services Translational Genomics Research Institute operates as non-profit organization. It focuses on developing earlier diagnoses and smarter treatments. Translational research applies to the development of diagnostics, prognostics, and therapies for cancer, neurological disorders, diabetes, and other complex diseases. The company was founded by Jeffrey M. Trent in 2002 and is headquartered in Phoenix, AZ. | Directeur/Membre du Conseil | - | - |
Historique de carrière de Cindy Parseghian
Anciens postes connus de Cindy Parseghian
Sociétés | Poste | Début | Fin |
---|---|---|---|
Critical Path Institute
![]() Critical Path Institute Miscellaneous Commercial ServicesCommercial Services Critical Path Institute is a nonprofit organization established in 2005 as a public and private partnership with the FDA's Critical Path Initiative program. The non-profit company is based in Tucson, AZ, and operates from Ireland with additional staff in multiple other locations. The company's mission is to catalyze the development of new approaches that advance medical innovation and regulatory science, accelerating the path to a healthier world. The company orchestrates the development of drug development tools through an innovative, collaborative approach to the sharing of data and expertise, and accelerate the pace and reduce the costs of medical product development by building consensus among the participating institutions. The company was founded in 2005 by Raymond L. Woosley, Glenn C. Rice. Daniel M. Jorgensen has been the CEO of the company since 2022. | Corporate Officer/Principal | - | - |
United Way of Tucson & Southern Arizona, Inc.
![]() United Way of Tucson & Southern Arizona, Inc. Miscellaneous Commercial ServicesCommercial Services United Way of Tucson & Southern Arizona, Inc. provides health and human services. The firm’s programs include cradle to career, days of caring and volunteer income tax assistance. The Company is headquartered in Tucson, AZ. | Directeur/Membre du Conseil | - | - |
Formation de Cindy Parseghian
Princeton University | Undergraduate Degree |
Statistiques
Internationale
Etats-Unis | 7 |
Opérationnelle
Director/Board Member | 2 |
Founder | 1 |
President | 1 |
Sectorielle
Commercial Services | 4 |
Government | 2 |
Consumer Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Entreprise privées | 5 |
---|---|
United Way of Tucson & Southern Arizona, Inc.
![]() United Way of Tucson & Southern Arizona, Inc. Miscellaneous Commercial ServicesCommercial Services United Way of Tucson & Southern Arizona, Inc. provides health and human services. The firm’s programs include cradle to career, days of caring and volunteer income tax assistance. The Company is headquartered in Tucson, AZ. | Commercial Services |
The Ara Parseghian Medical Research Foundation | |
Critical Path Institute
![]() Critical Path Institute Miscellaneous Commercial ServicesCommercial Services Critical Path Institute is a nonprofit organization established in 2005 as a public and private partnership with the FDA's Critical Path Initiative program. The non-profit company is based in Tucson, AZ, and operates from Ireland with additional staff in multiple other locations. The company's mission is to catalyze the development of new approaches that advance medical innovation and regulatory science, accelerating the path to a healthier world. The company orchestrates the development of drug development tools through an innovative, collaborative approach to the sharing of data and expertise, and accelerate the pace and reduce the costs of medical product development by building consensus among the participating institutions. The company was founded in 2005 by Raymond L. Woosley, Glenn C. Rice. Daniel M. Jorgensen has been the CEO of the company since 2022. | Commercial Services |
National Institute of Neurological Disorders & Stroke | Government |
Translational Genomics Research Institute
![]() Translational Genomics Research Institute Miscellaneous Commercial ServicesCommercial Services Translational Genomics Research Institute operates as non-profit organization. It focuses on developing earlier diagnoses and smarter treatments. Translational research applies to the development of diagnostics, prognostics, and therapies for cancer, neurological disorders, diabetes, and other complex diseases. The company was founded by Jeffrey M. Trent in 2002 and is headquartered in Phoenix, AZ. | Commercial Services |
- Bourse
- Insiders
- Cindy Parseghian
- Expérience